文献速递妇科肿瘤

探索子宫内膜癌中的孤立肿瘤细胞实体

Exploring isolated tumor cells entity in endometrial cancer.
PubMed 文献 · Eur J Cancer · 2025-06-18

本研究为多中心回顾性分析,纳入2018年6月至2024年5月间接受前哨淋巴结活检及分子分型的1821例子宫内膜癌患者,比较孤立肿瘤细胞(ITC)与N0及N+(微/宏转移)组的病理与分子特征。结果显示ITC可能代表一种早期淋巴结受累形式,生物学上不同于微转移和宏转移,并与MMR缺陷相关、p53异常较少,支持其侵袭性较低的生物学特征。

要点

  • 1821例中N0占84.5%、ITC占5.1%、微转移占5.3%、宏转移占4.5%
  • ITC组深肌层浸润67.7% vs N0组28.7%(p<0.001),弥漫性LVSI 52.1% vs 12.2%(p<0.001)
  • ITC组MMR缺陷33.3% vs N0组25.0%(p=0.07),p53异常与N+相关(19.4% vs ITC 7.3%,OR 0.33,p=0.008)

核心结论

  • 研究提示ITC可能是淋巴结受累的早期形式,生物学上不同于微转移和宏转移。
  • ITC与MMR缺陷相关且缺乏p53异常等侵袭性标志,支持其侵袭性较低的生物学特征。
  • 整合分子与病理特征可能有助于细化子宫内膜癌ITC患者的风险分层并指导管理策略。

研究设计与样本

  • 多中心回顾性分析,纳入2018年6月至2024年5月诊断的子宫内膜癌患者,均接受前哨淋巴结活检手术分期及分子分型。
  • 通过前哨淋巴结超分期或一步核酸扩增(OSNA)检出的ITC病例,与N0组及N+(微转移/宏转移)组进行比较。
  • 共纳入1821例患者。

主要发现

  • 淋巴结状态:N0占84.5%,ITC占5.1%,微转移占5.3%,宏转移占4.5%。
  • ITC组深肌层浸润占67.7%,N0组占28.7%(p<0.001)。
  • 弥漫性淋巴血管间隙浸润(LVSI)在ITC组为52.1%,高于N0组的12.2%(p<0.001)。
  • MMR缺陷在ITC组为33.3%,N0组为25.0%(p=0.07)。
  • POLE突变在N0组为4.2%、ITC组为3.1%,N+组为1.1%,差异无统计学意义;p53异常肿瘤与N+状态显著相关(19.4%),高于ITC组的7.3%(OR 0.33,p=0.008)。

临床怎么用

  • 具有低危特征的ITC患者未发生复发。
  • 作者认为整合分子与病理特征可能细化ITC患者风险分层并指导管理策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endometrial cancer (EC) management includes nodal staging and molecular classification. Despite molecular advancements, the biological significance of isolated tumor cells (ITC) in EC remains unclear. This study aimed to characterize ITC in the context of pathological and molecular features MATERIALS AND METHODS: A multicenter, retrospective analysis included EC patients diagnosed between June 2018 and May 2024 who underwent surgical staging via sentinel lymph node (SLN) biopsy and molecular profiling. ITC cases detected through SLN ultrastaging or One Step Nucleic Acid Amplification (OSNA) were compared with N0 and N + (micro-/macrometastasis) groups. RESULTS: Among the 1821 patients included, nodal status was N0 in 84.5 %, ITC in 5.1 %, micrometastases in 5.3 %, and macrometastases in 4.5 %. ITC patients exhibited deep myometrial invasion in 67.7 % of cases vs. 28.7 % in N0 (p < 0.001). Diffuse lymphovascular space invasion (LVSI) was significantly higher in ITC (52.1 %) than N0 (12.2 %, p < 0.001). MMR deficiency was more frequent in ITC (33.3 %) vs. N0 (25.0 %, p = 0.07). POLE mutations were more common in N0 (4.2 %) and ITC (3.1 %) vs. N + (1.1 %), though not statistically significant. p53-abnormal tumors were significantly associated with N + status (19.4 %) compared to ITC (7.3 %, OR 0.33, p = 0.008). No relapses occurred among ITC patients with low-risk features. CONCLUSIONS: These findings suggest that ITC may represent an early form of nodal involvement, biologically distinct from micro- and macrometastases. The association with MMR deficiency and the absence of aggressive markers such as p53 abnormalities support a less aggressive profile. Integrating molecular and pathological features may refine risk stratification and inform management strategies for EC patients with ITC.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Capozzi VA, Perrone E, Scarpelli E, et al. Exploring isolated tumor cells entity in endometrial cancer. Eur J Cancer. 2025. PMID: 40555033. doi:10.1016/j.ejca.2025.115586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。